Taking A Swipe At Mylan Inc., MEDA Preys On Its Own M&A Opportunities

Amid a wave of consolidation in the drug business, Meda AB (MEDAA) is ready to buy and double in size. Meda is preparing to embark on “transformational, strategic transactions” to achieve growth, Chief Executive Officer Joerg-Thomas Dierks said today on a conference call to discuss earnings. The Solna, Sweden-based company last week rejected a second takeover attempt by Mylan Inc.

Help employers find you! Check out all the jobs and post your resume.